Session

Biomarker in liver disease: Risk and prediction

DIAGNOSTIC AND PROGNOSTIC PERFORMANCE OF URINARY NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN IN PATIENTS WITH CIRRHOSIS AND ACUTE KIDNEY INJURY
DIAGNOSTIC AND PROGNOSTIC PERFORMANCE OF URINARY NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN IN PATIENTS WITH CIRRHOSIS AND ACUTE KIDNEY INJURY

NON-INVASIVE TESTS FOR CLINICALLY SIGNIFICANT PORTAL HYPERTENSION AFTER HCV-CURE – INDIVIDUAL PATIENT DATA META-ANALYSIS AND VALIDATION
NON-INVASIVE TESTS FOR CLINICALLY SIGNIFICANT PORTAL HYPERTENSION AFTER HCV-CURE – INDIVIDUAL PATIENT DATA META-ANALYSIS AND VALIDATION

DUCTULAR BILIRUBINOSTASIS IS A DIAGNOSTIC BIOMARKER FOR ACUTE-ON-CHRONIC LIVER FAILURE: RESULTS FROM A WELL-DEFINED COHORT OF PATIENTS WITH ALCOHOLIC STEATOHEPATITIS
DUCTULAR BILIRUBINOSTASIS IS A DIAGNOSTIC BIOMARKER FOR ACUTE-ON-CHRONIC LIVER FAILURE: RESULTS FROM A WELL-DEFINED COHORT OF PATIENTS WITH ALCOHOLIC STEATOHEPATITIS

CIRCULATING MIR-21 AND PREVALENCE OF IBD IN PSC PATIENTS
CIRCULATING MIR-21 AND PREVALENCE OF IBD IN PSC PATIENTS

MEAT CONSUMPTION AND PNPLA3 POLYMORPHISM ARE ASSOCIATED WITH FATTY LIVER IN A MULTI-CENTER CROSS-SECTIONAL STUDY
MEAT CONSUMPTION AND PNPLA3 POLYMORPHISM ARE ASSOCIATED WITH FATTY LIVER IN A MULTI-CENTER CROSS-SECTIONAL STUDY

MEAT CONSUMPTION AND PNPLA3 POLYMORPHISM ARE ASSOCIATED WITH FATTY LIVER IN A MULTI-CENTER CROSS-SECTIONAL STUDY
MEAT CONSUMPTION AND PNPLA3 POLYMORPHISM ARE ASSOCIATED WITH FATTY LIVER IN A MULTI-CENTER CROSS-SECTIONAL STUDY

Biomarker in liver disease: Risk and prediction  et al.

CIRCULATING MIR-21 AND PREVALENCE OF IBD IN PSC PATIENTS
CIRCULATING MIR-21 AND PREVALENCE OF IBD IN PSC PATIENTS

Biomarker in liver disease: Risk and prediction  et al.

DUCTULAR BILIRUBINOSTASIS IS A DIAGNOSTIC BIOMARKER FOR ACUTE-ON-CHRONIC LIVER FAILURE: RESULTS FROM A WELL-DEFINED COHORT OF PATIENTS WITH ALCOHOLIC STEATOHEPATITIS
DUCTULAR BILIRUBINOSTASIS IS A DIAGNOSTIC BIOMARKER FOR ACUTE-ON-CHRONIC LIVER FAILURE: RESULTS FROM A WELL-DEFINED COHORT OF PATIENTS WITH ALCOHOLIC STEATOHEPATITIS

Biomarker in liver disease: Risk and prediction  et al.

NON-INVASIVE TESTS FOR CLINICALLY SIGNIFICANT PORTAL HYPERTENSION AFTER HCV-CURE – INDIVIDUAL PATIENT DATA META-ANALYSIS AND VALIDATION
NON-INVASIVE TESTS FOR CLINICALLY SIGNIFICANT PORTAL HYPERTENSION AFTER HCV-CURE – INDIVIDUAL PATIENT DATA META-ANALYSIS AND VALIDATION

Biomarker in liver disease: Risk and prediction  et al.

DIAGNOSTIC AND PROGNOSTIC PERFORMANCE OF URINARY NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN IN PATIENTS WITH CIRRHOSIS AND ACUTE KIDNEY INJURY
DIAGNOSTIC AND PROGNOSTIC PERFORMANCE OF URINARY NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN IN PATIENTS WITH CIRRHOSIS AND ACUTE KIDNEY INJURY

Biomarker in liver disease: Risk and prediction  et al.

Item 1 - 10 / 10
1